Metabolic bone disease
Linda Russell, MD
Rheumatologist
Hospital for Special Surgery
Karen Hansen, MD, MS
University of Wisconsin
Elizabeth Shane, MD
Columbia University Medical Center
What is the evidence for and against antiresorptive therapy drug holidays? At this session, faculty will review the existing data and practical considerations in recommending drug holidays for patients on these therapies, as well as specific clinical situations of interest. They will examine clinical presentations of atypical femur fractures, osteonecrosis of the jaw and other adverse effects of antiresorptive therapy on bones.